Tumor Types
Filtrar los productos
Marcas
Ver todas las marcas
Tecnologías
Ver todas las tecnologías
Tumor Types
Marcas
Ver todas las marcas
Tecnologías
Ver todas las tecnologías
Productos de Tumor Types
EndoPredict®
Prognostic and predictive molecular in vitro test to determine the risk of recurrence and the absolute benefit of chemotherapy over the next 15 and 10 years, respectively, in patients with ER+/HER2- primary breast cancer.
Myriad Genetics
Prognosis
Real Time PCR (qPCR)
FusionPlex® Lung v2
NGS assay for the study of 17 genes involved in lung cancer.
Archer Dx
Fusions
Next Generation Sequencing (NGS)
FusionPlex® Sarcoma v2
NGS assays associated with soft tissue cancers.
Archer Dx
Fusions
Next Generation Sequencing (NGS)
Hedera Profiling 2 ctDNA test panel
NGS assay for the analysis of 32 genes associated with common solid tumors from circulating tumor DNA (ctDNA)
HederaDx
Digestive System
Next Generation Sequencing (NGS)
LIQUIDPlex Universal solid tumor
NGS assay to study 28 genes commonly associated with solid tumor type cancers from circulating cell-free tumor DNA (ccfDNA/cfDNA/ctDNA).
Archer Dx
Digestive System
Next Generation Sequencing (NGS)
MiniHRS kit (Mini Homologous Recombination)
Study of 4 genes associated with breast and ovarian cancer.
SOPHIA Genetics
Reproductive System
Next Generation Sequencing (NGS)
myChoice CDx
The most comprehensive tumor test to determine Homologous Recombination Deficiency (HDR) Status by studying the BRCA genes in patients with ovarian cancer.
Myriad Genetics
Prognosis
Next Generation Sequencing (NGS)
myChoice CDx PLUS
La prueba más completa para determinar el estado de deficiencia de la recombinación homóloga (HDR) estudiando los genes BRCA y 13 más adicionales, en pacientes con cáncer de ovario.
Myriad Genetics
HRD
Next Generation Sequencing (NGS)
Comunitary Solid Tumor Solutions
Analysis of 42 genes involved in the in the most common solid tumors: lung, colorectal, skin, and brain cancers
SOPHIA Genetics
Digestive System
Next Generation Sequencing (NGS)